
Feb 21 (Reuters) - Novo Nordisk A/S NOVOb.CO:
FDA: NOVO NORDISK'S OZEMPIC INJECTION .68 MG/1 ML, INJECTION 1.34 MG/1 ML, INJECTION 2.68 MG/1 ML AVAILABLE AS OF FEB 21 - WEBSITE
FDA: NOVO NORDISK'S WEGOVY, INJECTION, 1.7 MG/.75 ML , WEGOVY, INJECTION, 2.4 MG/.75 ML NOW AVAILABLE- WEBSITE
FDA SAYS SEMAGLUTIDE INJECTION SHORTAGE IS RESOLVED AS OF FEB 21 - WEBSITE
Further company coverage: [NOVOb.CO]